Ultralight nanofiber aerogels (NFAs) or nanofiber sponges are a truly three-dimensional derivative of the intrinsically flat electrospun nanofiber mats or membranes (NFMs). Here we investigated the potential of such materials for particle or aerosol filtration because particle filtration is a major application of NFMs. Ultralight NFAs were synthesized from electrospun nanofibers using a solid-templating technique. These materials had a tunable hierarchical cellular open-pore structure. We observed high filtration efficiencies of up to 99.999% at the most penetrating particle size. By tailoring the porosity of the NFAs through the processing parameters, we were able to adjust the number of permeated particles by a factor of 1000 and the pressure drop by a factor of 9. These NFAs acted as a deep-bed filter, and they were capable of handling high dust loadings without any indication of performance loss or an increase in the pressure drop. When the face velocity was increased from 0.75 to 6 cm s, the filtration efficiency remained high within a factor of 1.1-10. Both characteristics were in contrast to the behavior of two commercial NFM particle filters, which showed significant increases in the pressure drop with the filtration time as well as a susceptibility against high face velocities by a factor of 105.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsami.8b00455 | DOI Listing |
Med Sci Sports Exerc
December 2024
Department of Rehabilitation Sciences, Ghent University, Ghent, BELGIUM.
Purpose: Eccentric calf training for Achilles tendinopathy shows variable success in athletes. Recent insights suggest a role for tendon fluid flow (exudation or redistribution) during exercise, which explains post-exercise reductions in thickness and increases in stiffness of the tendon. This fluid flow is thought to be beneficial as it may promote tendon remodeling, reduce intratendinous pressure, and alleviate pain.
View Article and Find Full Text PDFCurr Opin Ophthalmol
January 2025
New York Eye Surgery Center, New York City, New York, USA.
Purpose Of Review: This review highlights new Federal Drug Administration (FDA) approved glaucoma treatments to familiarize providers with immediately available options.
Recent Findings: New FDA-approved treatments include the bimatoprost implant, travoprost implant, direct selective laser trabeculoplasty (DSLT), and ocular pressure adjusting pump. The bimatoprost implant is approved for a single administration with effects lasting for about 1 year, as opposed to the nearly 3-year effect for the travoprost implant.
R Soc Open Sci
January 2025
Fundamental and Applied Sciences Department, Centre of Ionic Liquids, Universiti Teknologi PETRONAS, Seri Iskandar, Perak Darul Ridzuan 32610, Malaysia.
Six 1,8-diazabicyclo(5.4.0)undec-7-ene-based ionic liquids (ILs) linked with ethyl or propyl hydroxyl cations, coupled with thiocyanate, dicyanamide and bistriflimide anions, were synthesized through a two-step reaction: quaternization and ion exchange.
View Article and Find Full Text PDFLangmuir
January 2025
Department of Chemical Engineering, Indian Institute of Technology, Guwahati 781039, Assam, India.
Self-organized contact line instabilities (CLI) of a macroscopic liquid crystal (LC) droplet can be an ingenious pathway to generate a large collection of miniaturized LC drops. For example, when a larger drop of volatile solvent (e.g.
View Article and Find Full Text PDFMol Pharm
January 2025
School of Pharmacy, University of Eastern Finland, Yliopistonranta 1 C, 70210 Kuopio, Finland.
Glaucoma is a vision-threatening disease that is currently treated with intraocular-pressure-reducing eyedrops that are instilled once or multiple times daily. Unfortunately, the treatment is associated with low patient adherence and suboptimal treatment outcomes. We developed carbonic anhydrase II inhibitors (CAI-II) for a prolonged reduction of intraocular pressure (IOP).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!